Repositorio Dspace
Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | Córdova, Ezequiel | |
| dc.contributor.author | Rolle, Charlotte-Paige | |
| dc.contributor.author | Hove, Kai | |
| dc.contributor.author | Felizarta, Franco | |
| dc.contributor.author | Johnson, Marc | |
| dc.contributor.author | Cuevas-Tascon, Guillermo | |
| dc.contributor.author | Molina, Jean-Michel | |
| dc.contributor.author | Bravo-Urbieta, Joaquín | |
| dc.contributor.author | Hocqueloux, Laurent | |
| dc.contributor.author | Lupo, Sergio | |
| dc.contributor.author | Pérez, Carlos-M | |
| dc.contributor.author | Ole-Jensen, Bjorn-Erik | |
| dc.contributor.author | Jonsson-Oldenbuttel, Celia | |
| dc.contributor.author | Zamora-Vargas, Francisco-Xavier | |
| dc.contributor.author | Szabo, Jason | |
| dc.contributor.author | Cahn, Pedro | |
| dc.contributor.author | Antinori, Andrea | |
| dc.contributor.author | López-Bernaldo-de-Quiros, Juan-Carlos | |
| dc.contributor.author | Castagna, Antonella | |
| dc.contributor.author | Bui, Monika | |
| dc.contributor.author | Grove, Richard | |
| dc.contributor.author | Wang, Kehui | |
| dc.contributor.author | St-Clair, Marty | |
| dc.contributor.author | Moodley, Riya | |
| dc.contributor.author | Radford, Jacob | |
| dc.contributor.author | Priest, Julie | |
| dc.contributor.author | Gutner, Cassidy-A | |
| dc.contributor.author | Jacob, Ian | |
| dc.contributor.author | Chatterjee, Avishek | |
| dc.contributor.author | Somvanshi, Suryakant | |
| dc.contributor.author | Kolobova, Irina | |
| dc.contributor.author | Trehan, Rekha | |
| dc.contributor.author | Polk, Christopher | |
| dc.contributor.author | Patel, Parul | |
| dc.contributor.author | de-los-Rios, Patricia | |
| dc.contributor.author | DiMondi, Paul | |
| dc.contributor.author | Gordon, Lori-A | |
| dc.contributor.author | Brown, Kimberley | |
| dc.contributor.author | Garges, Harmony-P | |
| dc.contributor.author | Jones, Bryn | |
| dc.contributor.author | van-Wyk, Jean | |
| dc.date.accessioned | 2026-10-28T08:17:06Z | |
| dc.date.available | 2026-10-28T08:17:06Z | |
| dc.date.issued | 2026-09-01 | |
| dc.identifier.citation | Córdova E, Rolle CP, Hove K, Felizarta F, Johnson M, Cuevas Tascón G, et al. Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study. Open Forum Infectious Diseases. 1 de septiembre de 2026;13(9):ofag383. doi:10.1093/ofid/ofag383 | |
| dc.identifier.issn | 2328-8957 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/29047 | |
| dc.language.iso | eng | |
| dc.publisher | OXFORD UNIV PRESS INC | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.title | Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.relation.publisherversion | https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofag383/8741827 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1093/ofid/ofag383 | |
| dc.journal.title | Open Forum Infectious Diseases |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona